The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InProspera Financial Services Inc. reduced its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 38.0% during the third quarter, now holding 8,766 shares valued at $4.93 million. This portfolio adjustment comes despite Regeneron reporting a significant beat on its third-quarter earnings expectations. The company posted an EPS of $11.44 and revenues of $3.88 billion, surpassing analyst estimates. Furthermore, Regeneron increased its quarterly dividend, signaling robust financial performance. Analysts maintain a "Moderate Buy" consensus rating for the stock, with a target price of $793.81. These developments present mixed signals for investors, balancing institutional portfolio adjustments against strong underlying company fundamentals.